Quantum BioPharma Ltd C.QNTM

FSD PHARMA - PROGRESS

[wendhie05]

This is how FSD Pharma doing it. The US Food and Drug Administration (FDA) has authorized the initiation of a Phase 2 study of FSD-201 on COVID-19 patients. The company plans to start oral dosing (tablets) more than 300 patients in October this year. The company completed a Phase 1 first-in-human safety and tolerability study for FSD201 in Australia. 

[colleenn]

Great! A.G.P./Alliance Global Partners acted as sole placement agent for the offering

[colleenn]

Wow! The Company has also granted A.G.P./Alliance Global Partners an option to arrange for purchases of up to an additional US$10.0 million of Securities on the terms above for a period of 30 days following the initial closing.